Telomerase inhibitors - TMPyP4, BIBR 1532 and imetelstat - alter the adhesion potential of breast cancer MCF7 and MDA-MB-231 cells that leads to impaired ability to form spheroids
Przemysław Kopczyński(Poznan University of Medical Sciences), Błażej Rubiś(Poznan University of Medical Sciences), Jacek Kujawski(Poznan University of Medical Sciences), Aleksandra Romaniuk-Drapała(Poznan University of Medical Sciences), Kinga Rygiel(Poznan University of Medical Sciences)
Cited by 0
Related Papers
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
|International Journal of Molecular Sciences|2019|42
The Role of Telomerase in Breast Cancer’s Response to Therapy
|International Journal of Molecular Sciences|2022|39